Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...
A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.
Researchers have published findings from the phase 2 LITESPARK-003 study of patients with previously untreated advanced clear ...
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
During a live event, Kathryn E. Beckermann, MD, PhD, discussed the treatment of RCC with insights from a recent trial on ...
Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ...
Management of advanced renal cell carcinoma remains a persistent clinical challenge with high morbidity and mortality for a large proportion of patients. Until recently, available medical ...
Hosted on MSN1d
Dwyane Wade diagnosis: What to know about kidney cancerRetired NBA legend Dwyane Wade revealed his kidney cancer diagnosis on a recent podcast episode. Here's what to know about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback